Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer
NCT04597411
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
101
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Neoplasms, Castration-Resistant
Interventions
RADIATION:
225^Ac-PSMA-617
RADIATION:
68^Ga-PSMA-11
Sponsor
Endocyte